Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE1
Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) as Therapy for Previously Treated Chronic Lymphocytic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974)
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- NA
Phase 1b Safety and Efficacy Study of TRU-016
- Status
- TERMINATED
- Phase
- PHASE1
Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Allogeneic Stem Cell Transplant for CLL
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3